AVILA THERAPEUTICS
Avila Therapeutics designs and develops covalent drugs for viral infections, cancers, and autoimmune diseases. It offers AVL-181, a small molecule hepatitis C virus protease inhibitor. Avila Therapeutics has a strategic alliance with Sanofi-Aventis. The company was incorporated in 2006 and is based in Waltham, Massachusetts. As of March 7, 2012, Avila Therapeutics operates as a subsidiary of Celgene Corporation.
AVILA THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2006-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.avilatx.com
Total Employee:
11+
Status:
Active
Contact:
781-891-0086
Email Addresses:
[email protected]
Total Funding:
59.28 M USD
Technology used in webpage:
CSC Global DNS CDNS Network
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Madronish Therapeutics
Madronish Therapeutics, LLC (MTL) is a biotechnology company focused on immuno-oncology strategies to either enhance immune response.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Employees Featured
Founder
Investors List
Abingworth
Abingworth investment in Series B - Avila Therapeutics
Advent Venture Partners
Advent Venture Partners investment in Series B - Avila Therapeutics
Avila Venture Capital
Avila Venture Capital investment in Series B - Avila Therapeutics
Polaris Venture Capital
Polaris Venture Capital investment in Series B - Avila Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Avila Therapeutics
Atlas Venture
Atlas Venture investment in Series B - Avila Therapeutics
Abingworth
Abingworth investment in Series A - Avila Therapeutics
Polaris Partners
Polaris Partners investment in Series A - Avila Therapeutics
Advent Venture Partners
Advent Venture Partners investment in Series A - Avila Therapeutics
Atlas Venture
Atlas Venture investment in Series A - Avila Therapeutics
Official Site Inspections
http://www.avilatx.com
- Host name: 165.160.13.20
- IP address: 165.160.13.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
